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Abstract
Background: Choosing the most performing method in terms of outcome prediction or variables selection is a
recurring problem in prognosis studies, leading to many publications on methods comparison. But some
aspects have received little attention. First, most comparison studies treat prediction performance and variable
selection aspects separately. Second, methods are either compared within a binary outcome setting (based on
an arbitrarily chosen delay) or within a survival setting, but not both. In this paper, we propose a comparison
methodology to weight up those different settings both in terms of prediction and variables selection, while
incorporating advanced machine learning strategies.
Methods: Using a high-dimensional case study on a sickle-cell disease (SCD) cohort, we compare 8 statistical
methods. In the binary outcome setting, we consider logistic regression (LR), support vector machine (SVM),
random forest (RF), gradient boosting (GB) and neural network (NN); while on the survival analysis setting,
we consider the Cox Proportional Hazards (PH), the CURE and the C-mix models. We then compare
performances of all methods both in terms of risk prediction and variable selection, with a focus on the use of
Elastic-Net regularization technique.
Results: Among all assessed statistical methods assessed, the C-mix model yields the better performances in
both the two considered settings, as well as interesting interpretation aspects. There is some consistency in
selected covariates across methods within a setting, but not much across the two settings.
Conclusions: It appears that learning withing the survival setting first, and then going back to a binary
prediction using the survival estimates significantly enhance binary predictions.
Keywords: Hospital readmission risk; High-dimensional prediction; Survival analysis; Machine learning
methods; Sickle-cell disease
Background
Recently, many statistical developments have been
performed to tackle prognostic studies analysis. Be-
yond accurate risk estimation, interpretation of the re-
sults in terms of covariates importance is required to
assess risk factors, with the ultimate aim of developing
better diagnostic and therapeutic strategies [37].
In most studies, covariate selection ability and model
prediction performance are regarded separately. On
the one hand, a considerable amount of studies report
on covariates relevancy in multivariate models, mostly
in the form of ajusted odds ratio [31] (for instance
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using logistic regression (LR) model [2, 33]) with-
out reporting on the method’s prediction performance
(goodness-of-fit and overfitting aspects are neglected);
namely disregarding the question: is the model pre-
diction still accurate on new data, unseen during the
training phase? While on the other hand, most studies
focusing on a method’s predictive performance do not
mention its variable selection ability [21], thus mak-
ing it not well suited for the high-dimensional setting.
Such settings are becoming increasingly common in a
context where the number of available covariates to
consider as potential risk factors is tremendous, espe-
cially with the development of electronic health record
(EHR).
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In this paper, we discuss both aspects (prediction
performance and covariates selection) for all consid-
ered methods, with a particular emphasis on the
Elastic-Net regularization method [51]. Regularization
has emerged as a dominant theme in machine learning
and statistics. It provides an intuitive and principled
tool for learning from high-dimensional data.
Then, a lot of studies consider prognosis as a bi-
nary outcome, namely whether the event-of-interest
(death, relapse or hospital readmission for instance)
occurs whithin a pre-specified period of time we de-
note  [5, 41, 44, 47]. In the following, we refer to
this framework as the binary outcome setting, and we
denote T ≥ 0 the time elapsed before the event-of-
interest and X ∈ Rd the vector of d covariates recorded
at the hospital during a stay. In this setting, we are in-
terested in predicting T ≤ . Such an a priori choice
for  is questionable, since any conclusion regarding
both prediction and covariates relevancy is completely
conditioned on the threshold value  [12]. Hence, it
is hazardous to make general inference on the proba-
bility distribution of the time-to-event outcome given
the covariates from such a restrictive binary prediction
setting.
An alternative setting to model prognosis is the sur-
vival analysis one, that takes the quantitative censored
times as outcomes. The time T is right censored since
in practice, some patients have not been readmitted
before the end of follow-up. In the following, we re-
fer to this setting as the survival analysis setting [27]
and we denote Y the right-censored duration, that is
Y = min(T,C) with C the time when the patient is
lost to follow-up. Few studies compare the survival
analysis and binary outcome settings and none of them
considers simultaneously the prediction and the vari-
able selection aspects in a high dimensional setting.
For instance in Chen et al. [12], only the Cox Pro-
portional Hazards (PH) model [13] is considered in
the survival analysis setting and a dimentionality re-
duction phase (or screening) is performed prior to the
models comparison, as it is often the case [6, 14].
Our case study focuses on hospital readmission fol-
lowing vaso-occlusive crisis (VOC) for patients with
sickle-cell disease (SCD). SCD is the most frequent
monogenic disorder worldwide. It is responsible for re-
peated VOC, which are acute painful episodes, utli-
mately resulting in increased morbidity and mortal-
ity [10, 38]. Although there are some studies regard-
ing risk factors of early complications, only a few
of them specifically addressed the question of early-
readmission prediction after a VOC episode [9, 40].
For a few decades, hospital readmissions have been
known to be responsible for huge costs [18, 28]; they
are also a measure of health care quality. Today, hos-
pitals have limited ressources they can allocate to each
patient. Therefore, identifying patients at high risk of
readmissions is a paramount question and predictive
models are often used to tackle it.
The purpose of this manuscript is to compare dif-
ferent statistical methods to analyse readmission. To
make such comparisons, we consider both the predic-
tive performance and the covariates selection aspect
of each model, on the same high-dimensional set of
covariates.
In the binary outcome setting, we consider LR [25]
and support vector machine (SVM) [42] with linear
kernel, being both penalized with the Elastic-Net reg-
ularization [51] to deal with the high dimensional set-
ting and avoid overfitting [23]. We also consider ran-
dom forest (RF) [8], gradient boosting (GB) [19] and
artificial neural networks (NN) [49].
We then abstain from the a priori threshold choice
and consider the survival analysis setting. We apply
first the Cox PH model [13]. We also apply the CURE
model [16, 30], that considers one fraction of the popu-
lation as cured or not subject to any risk of readmims-
sion. Finally, we consider the recently developped high
dimensional C-mix mixture model [11]. The three con-
sidered models in this setting are also penalized with
the Elastic-Net regularization.
Methods
Motivating case study
We consider a monocentric retrospective cohort study
of n = 286 patients. George Pompidou University Hos-
pital (GPUH) is an expertise center for SCD adult pa-
tients [1]. Data is extracted from the GPUH Clinical
Data Warehouse (CDW) using the i2b2 star-shaped
standard [50]. It contains routine care data divided
into several categories among them demographics, vi-
tal signs, diagnoses (ICD-10 [34]), procedures (French
CCAM classification [45]), EHR clinical data from
structured questionnaires, free text reports, Logical
Observation Identifiers Names and Codes (LOINC),
biological test results, and Computerized Provider Or-
der Entry (CPOE) drug prescriptions. The sample in-
cluded all stays from patients admitted to the internal
medicine department for VOC (ICD-10 57.0 or 57.2)
between January 1st 2010 and December 31st 2015.
Over half of the patients has only one stay during the
follow-up period. We hence randomly sample one stay
per patient and focus on the early-readmission risk af-
terwards. This enables us, in addition, to work on the
independent and identically distributed standard sta-
tistical framework.
Covariates
We extracted demographic data (e.g. sex, date of birth,
last known vital status), as well as both qualitative
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(e.g. the admission at any point during the stay to an
ICU, the type of opioid drug received) and quantitative
time-dependent variables (e.g. biological results, vital
sign values, intraveinous opiod syringes parameters)
regarding each stay.
We also extracted all the free text reports from the
patients’ EHR regardless of the source department
and the stay. In order to facilitate variable extraction
from such textual reports, we used a locally devel-
oped browser-accessible tool called FASTVISU [15].
This software is linked with the CDW, and allowed
us to quickly check throughout these textual reports
for highlighted information and to vote for variable
status (e.g. SCD genotype) or value (e.g. baseline
hemoglobinemia). Keywords using regular expressions
are used to focus on specific mentions within the text.
Variables extracted using this tool were the following:
SCD genotype, baseline hemoglobinemia, medical his-
tory (with a focus on previous VOC complications and
SCD-related chronic organ damages), and lifestyle re-
lated information. For time-dependent variables, sta-
tus was determined per stay, including the ones that
were not related to a VOC episode (e.g. annual check-
ups).
We extracted for the included patients all stays en-
coded as VOC to derive time length from and until the
respectively previous and consecutive stays. Regard-
ing demographic data, we derived the patient’s age at
admission for each stay. For each time-dependent co-
variate, all patient relative time series have different
number of points and different length. We then pro-
pose a method to extract several covariates from each
time series, to make the use of usual machine learning
algorithms possible:
• Regarding all vital parameters and oxygen use, we
derived them by calculating the average value and
the linear regression’s slope for the last 48 hours
of the stay, as well as the delay between the end
of oxygen support and the hospital discharge.
• Regarding biological variables, we only kept the
ones that were measured at least once for more
than 50% of the stays. We considered the last
measured value for each of them before discharge.
Additionally, for covariates with at least 2 dis-
tinct measurements per stay, we considered the
linear regression’s slope for the last 48 hours of
the stay. In order to maximize the amount of bio-
logical data, we also retrieved the biological values
measured in the emergency department, prior to
the administrative admission of the patient.
• For each time-dependent covariate and for each
stay, we fit a distinct Gaussian process on the
last 48 hours of the stay for all patient with at
least 3 distinct measurements during this period,
and extract the corresponding hyper-parameters
as covariates for our problem.
Indeed, Gaussian processes are known to fit EHR
data well; see for instance Pimentel et al. [36], where a
distinct Gaussian process is also fitted for each patient
and each time-dependent covariate, in order to clus-
ter patients into groups in the hyper-parameter space.
In our study, we instead use the hyper-parameters as
covariates in a supervised learning way. We use Gaus-
sian process with linear average function and a sum-
kernel composed by a constant kernel which modifies
the mean of the Gaussian process, a radial-basis func-
tion kernel, and a white kernel to explain the noise-
component of the signal.
After a binary encoding of the categorical covariates,
the final dimension of the working space (number of
considered covariates) is d = 174. Therefore, the num-
ber of patients is less than 2 times as many as the num-
ber of covariates, making it difficult to use standard re-
gression techniques. More details on data extraction,
missing data imputation, as well as a precise list of
all considered covariates, are given in Sections ??, ??
and ?? of Supplementary Material respectively.
Statistical methods and analytical strategies
Binary outcome setting
In this setting, we consider as early-readmission any
readmission occuring within 30 days of hospital dis-
charge after a previous hospital stay for VOC, the 30
days threshold being a standard choice in SCD stud-
ies [9, 17]. A first drawback of this setting (which is
rarely mentionned) is that patients having both a cen-
sored time and ci ≤  have to be excluded from the
procedure, since we do not know if ti ≤  or not. Fig-
ure 1 gives an illustration of this last point. In our
case, 7 patients have to be excluded because of this
issue.
We first consider LR [25] and linear kernel SVM [42],
both penalized with the Elastic-Net regularization [51].
For a given model, using this penalization means
adding the following term γ
(
(1− η)‖β‖1 + (η/2)‖β‖22
)
to the cost function (the negative likelihood for in-
stance) in order to minimize it in β ∈ Rd, a vector of
coefficients that quantifies the impact of each biomed-
ical covariates on the associated prediction task. This
means that the Elastic-Net regularization term is a lin-
ear combination of the lasso (`1) and ridge (squared `2)
penalties for a fixed η ∈ (0, 1), tuning parameter γ, and
where we denote ‖β‖p =
(∑d
i=1 |βi|p
)1/p
the `p-norm
of β. One advantage of this regularization method is its
ability to perform model selection (for the lasso part)
and to pinpoint the most important covariates rela-
tively to the prediction objective. On the other hand,
the ridge part allows to handle potential correlation
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Figure 1: Illustration of the problem of cen-
sored data that cannot be labeled when using
a threshold . δi = 1{Ti≤Ci} is the censoring
indicator which is equal to 1 if Yi is censored
and 0 otherwise. In the binary outcome set-
ting, patient 4 would be excluded.
between covariates [51]. The penalization parameter
γ is carefully chosen using the same cross-validation
procedure [29] for all competing models. Note that in
practice, the intercept is not regularized.
We also consider other machine learning algorithms
in the ensemble methods class such as RF [8] and
GB [19]. For both algorithms, all hyper-parameters are
tuned using a randomized search cross-validation pro-
cedure [3]. For instance for RF: the number of trees
in the forest, the maximum depth of the tree or the
minimum number of samples required to split an in-
ternal node. Note also that regarding the covariates
importance for RF and GB, we use the Gini impor-
tance [32], defined as the total decrease in node impu-
rity weighted by the probability of reaching that node
(which is approximated by the proportion of samples
reaching that node) averaged over all trees of the en-
semble. That is why the corresponding coefficients are
all positive for those two models, which is to be kept
in mind. Finally, we consider NN [49] in the form of
a multilayer perceptron neural network with one hid-
den layer. We use stochastic gradient-based optimizer
for NN and rectified linear units activation function
to get sparse activation and be able to compare co-
variate importance [20]. The regularization term as
well as the number of neurons in the hidden layer are
also cross-validated though a random search optimiza-
tion. Note that many studies in the literature choose
hyper-parameters of the models, without mentioning
any statistical procedure to determine them without a
priori [39].
For all considered models in this setting, we use the
reference implementations from the scikit-learn li-
brary [35].
Survival analysis setting
The Cox PH model is by far the most widely used in
the survival analysis setting; see Cox [13] and Simon
et al. [43] for the penalized version. It is a regression
model that describes the relation between intensity of
events and covariates, given by λ(t) = λ0(t)exp(x
>β)
where λ0 is a baseline intensity describing how the
event hazard changes over time at baseline levels of
covariates, and β is a vector quantifying the multi-
plicative impact on the hazard ratio of each covariate.
We use the R packages survival and glmnet to train
this model. An alternative to the Cox PH model is
the CURE model [16] that considers one fraction of
the population as not subject to any risk of readmis-
sion, with a logistic function for the incidence part
and a parametric survival model. We add an Elastic-
Net regularization term and use the appropriate im-
plementation detailed in Additional file 2. Finally, we
apply the C-mix model [11] that is designed to learn
risk groups in a high dimensional survival setting. For
a given patient i, it provides a marker piβˆ(xi) estimat-
ing the probability that the patient is at high risk of
early-readmission. Note that βˆ denotes the estimate
vector after the training phase for any model.
We randomly split data into a training set and a test
set (30% for testing, cross-validation is done on the
training). In both binary outcome and survival analy-
sis settings, all the prediction performances are evalu-
ated on the test set after the training phase, using the
relevant metrics detailed hereafter. Note also that for
all considered models (except RF and GB), continu-
ous covariates are standardized through a preprocess-
ing step, which allows proper comparability between
the covariates’ effects whithin each model.
Metrics used for analysis
In the binary outcome setting, the natural metric
used to evaluate performances is the AUC [7]. In
the survival analysis setting, the natural equivalent
is the C-index (implemented in the python package
lifelines), that is P[Mi > Mj |Yi < Yj , Yi < τ ] with
i 6= j two independent patients, τ corresponding to
the follow-up period duration [24], and Mi the natural
risk marker of the model for patient i: exp(x>i βˆ) for
the Cox PH model, the probability of being uncured
for the CURE model and piβˆ(xi) for the C-mix.
To compare the two settings, one can predict the
survival function Sˆi for each model and for patients
i in the test set. Then, for a given threshold , one
can now use Sˆi(|Xi = xi) for each model to predict
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whether or not Ti ≤  on the test set – relaying to the
binary outcome setting – thus assessing performances
using the classical AUC score. Then, with  = 30 days,
one can directly compare prediction performances with
those obtained in the binary outcome setting. Details
on the survival function estimation for each model are
given in Section ?? of Supplementary Material.
Finally, we compute the pairwise Pearson correlation
between the absolute (because of the positive vectors
for RF and GB) covariates importance vectors of each
method to obtain a similarity measure in terms of co-
variates selection [26].
Results
Table 1 compares the prediction performances of the
different methods in both considered settings using
appropriate metrics. Corresponding hyper-parameters
obtained by cross-validation are detailed in Section ??
of Supplementary Material.
Table 1: Comparison of prediction performances in the
two considered settings, with best results in bold.
Setting Metric Model Score
CURE 0.718
Survival analysis C-index Cox PH 0.725
C-mix 0.754
SVM 0.524
GB 0.561
LR 0.616
NN 0.707
Binary outcome AUC RF 0.738
CURE ( = 30) 0.831
Cox PH ( = 30) 0.855
C-mix ( = 30) 0.940
Thus, making binary predictions from survival anal-
ysis models using estimated survival function highly
improves performances. The C-mix yields the best re-
sults. Figure 2 displays the estimated survival curves
for the low and high risk of early-readmission sub-
groups learned by this model. Note the clear separation
between the two subgroups.
Based on those early-readmission risk learned sub-
groups, we test for significant differences between them
using Fisher-exact test [46] for binary covariate, and
Wilcoxon rank-sum test [48] for quantitative covari-
ate. Then, we similarly test for significant difference,
on each covariate, between naively created groups ob-
tained with the binary outcome setting ( = 30 days).
We also use the log-rank test [22] on each covariate,
directly involving quantitative readmission delays. Fi-
nally, we compared the obtained significance (the p-
value) for each test, on each covariate. The tests in-
duced by the C-mix model are the most significant
ones for almost all covariates. The top-6 p-values of
the tests are compared in Figure 3.
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Figure 2: Estimated survival curves per sub-
groups (blue for low risk and red for high risk)
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Figure 3: Comparison of the tests based on
the C-mix groups, on the  = 30 days rela-
tive groups and on survival times. We arbi-
trarily shows only the tests with correspond-
ing p-values below the level α = 5%, with the
classical Bonferroni multitests correction [4].
Taking the most significant C-mix groups high-
lighted in Figure 3, Figure 6 shows either boxplot (for
quantitative covariates) or repartition (for qualitative
covariates) comparison between those groups. One can
now easily visualize and interpret early-readmission
risk data-driven grouping, and focus on specific covari-
ate. For instance, it appears that patients among the
high risk group tend to have a lower hemoglobin level,
as well as a slightly lowering diastolic blood pressure in
the last 48 hours of the stay (while slightly uppering for
the low risk group). It also appears that less patients
among the low risk group have visited the emergency
department in the last 18 months.
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Figure 5: Pearson correlation matrix for com-
paring covariates selection similarities between
methods. Red means high correlations.
Let us now focus on the covariates selection aspect
for each method. Figure 4 gives an insight on the co-
variates importance relatively to each model for 20 ar-
bitrarily chosen covariates (selected on decreasing im-
portance order for the C-mix model). The result with
all covariates can be found in Section ?? of Supple-
mentary Material. One can observe some consistency
between methods. Figure 5 gives a global similarity
comparison measure in terms of covariates selection.
We observe higher similarities between methods within
a single setting.
Discussion
In this paper, rather than trying to be exhaustive in
terms of considered methods, we choose, accordingly
with the aim of this paper, to offer a methodology for
fairly comparing methods in the two considered set-
tings. Also, we do not try different  values, as it is
done in Chen et al. [12] (where emphasis is on perfor-
mance metrics), since our focus is to propose a general
comparison and interpretation methodology, with an
analysis that remains valid for any choice of  value.
In the binary outcome setting, classifiers highly de-
pend on how the risk groups are defined: a slight
change of the survival threshold  for assignment of
classes can lead to different prediction results [12]. In
our dataset, only 5.2% of the visits lead to a readmis-
sion within 30 days. We are then in a classical setup
where the adverse event appears rarely in the data at
our disposal. In such setting, a vast amount of tem-
poral information is lost since the model only knows
if a readmission occurs before the threshold delay or
not. It appears that taking all the information through
the survival analysis setting first, and then going back
to a binary prediction using the survival estimate, sig-
nificantly enhances any binary prediction, which intu-
itively makes sense.
Among all methods, the C-mix holds the best results.
Its good performances compared to other methods is
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Figure 6: Covariates boxplot comparison between
the most significant C-mix groups.
already shown in Bussy et al. [11], both in synthetic
and real data. While the Cox PH regression model
is widely used to analyze time-to-event data, it re-
lies on the proportional hazard ratio assumption. But
in the case of VOC for instance, it is plausible that
these early-readmissions are the consequences of the
same ongoing crisis (hospital discharge before the VOC
recovery), whereas late-readmissions are genuine new
unrelated crisis (recurrence). This would suggest that
the proportional hazard ratio assumption for Cox PH
model (or its related models like the competing risks
model, the marginal model or the frailty model; for this
reason not considered in this study) is not respected
in this situation. The CURE model main hypothesis
being that a proportion of the patient is cured is ques-
tionable too. Those reasons partly explain the good
performances of the C-mix model that does not rely
on any restrictive hypothesis.
In this study, data extraction was performed with
no a priori on the relevance of each variable. For in-
stance, we extracted all biological covariates that have
been measured during a patient’s stay, without pre-
suming of their importance on readmission risk. Se-
lected variables in our use case are relevant from a
clinical point of view, highlighting the capacity of reg-
ularization methods to pinpoint clinically relevant co-
variates.
The most important covariates in the survival setting
are linked to the severity of the underlying SCD (e.g.
crisis frequency, baseline hemoglobin), while selected
covariates in the binary outcome setting are more re-
lated to the crisis biological parameters (e.g. arterial
blood gas parameters). Some covariates appear to be
selected in both settings (e.g. mean lactate deshydro-
genase). All selected covariates make sens from a clin-
ical point of view, and the difference between the two
settings seems to be related to the underlying hypothe-
ses of each setting: as binary setting only takes infor-
mation on early readmission, crisis related parameters
are favored; meanwhile in the survival setting, param-
eters related to the severity of the underlying SCD are
favored. This underlines why it is crucial, when work-
ing on prognosis analysis, to use several methods to
get an insight of the most important covariates.
Conclusions
In this paper, we compare methods in terms of predic-
tion performances and covariates selection for different
statistical and machine learning methods on a readmis-
sion framework with high dimensional EHR data. We
particularly focus on comparing survival and binary
outcome settings. Methods from both settings must be
considered when working on a prognosis study. Indeed,
important covariates are possibly different depending
on the setting: for instance in our case study, we high-
light important covariates linked either to the severity
of the underlying SCD or to the severity of the crisis.
Not only do frequent readmissions affect SCD pa-
tients’ quality of life, they also impact hospitals’ or-
ganization and induce unnecessary costs. Our study
lays the groundwork for the development of powerful
methods which could help provide personalized care.
Indeed, such early-readmission risk-predicting tools
could help physicians decide whether or not a specific
patient should be discharged of the hospital. Neverthe-
less, most selected covariates were derived from raw or
unstructured extracted data, making it difficult to im-
plement the proposed predictive models into routine
clinical practice.
All results in the binary outcome setting rely on a
critical readmission delay choice, which is a question-
able - if not counterproductive - bias in readmission
risk studies. Additionally, we point out the idea that
learning in the survival setting, rather than directly
from the binary outcome setting, and then making bi-
nary predictions through the estimated survival func-
tion for a given delay threshold can dramatically en-
hance performances.
Finally, the C-mix model yields the better perfor-
mances and can be an interesting alternative to more
classical methods found in the medical literature to
deal with prognosis studies in a high dimensional
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framework. Moreover, it provides powerful interpre-
tations aspects that could be useful in both clinical
research and daily practice (see Figure 6). It would
be interesting to generalize our conclusions to external
datasets, which is the purpose of further investigations.
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1 Details on covariates
1.1 Covariates creation
Since SCD patients are frequently treated with opioids to control the pain induced
from VOCs, some may develop, over time, an addiction to these products. Such
addiction may cause readmission and often interferes with hospitalization timeline.
In order to limit confusion bias, we excluded patients encoded as opioid addicts
(ICD-10 F11) as well as those who were treated with substitute products such as
Methadone or Buprenorphine, both determined from hospitalization reports and
drug prescriptions.
Regarding opioid treatment related information from the CDW, based on doctors
and nurses inputs, variables extracted were the following:
- the specific molecule of each prescription,
- the specific dosage form of each prescription,
- the initiation and ending timestamps of each prescription.
From these variables, we also derived the following:
- the delay between the end of the last syringe received and the hospital discharge,
- the number of syringes used per day on average,
- the slope from the linear regression of the delay between syringes throughout the
stay.
Regarding intravenous opioid treatments, we also extracted bolus dosage, maxi-
mum dosage, and refractory period. In order to capture both the average level and
the general trend of these covariates, we derived them by calculating the slope and
intercept from the linear regression of each of these parameters throughout the stay.
1.2 Missing data
We substitute missing medical history related data as follows: if a specific medical
condition or VOC complication is mentioned in a report, this item is considered as
part of the patient’ medical history for every chronologically following stays; if a
specific medical condition or VOC complication is explicitly stated as absent from
the medical history in a report, this item is considered absent in all the previous
stays.
For other specific covariates, we proceed that way:
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- for the patients’ baseline hemoglobin value, we use the last hemoglobin value mea-
sured during the first included stay,
- for the dichotomous variables regarding the patient’s entourage and professional
activity, we use the most represented value amongst all stays (of all patients),
- we consider non-mentioned medical history or VOC complications as absent,
- we consider that all patients received both opioid treatments and oxygen therapy
at admission in the emergency room. Therefore, we consider the post-opioid obser-
vation period, as well as the post-oxygen observation period, to be the same time
length as the entire stay.
For all remaining covariates, we impute as follows (after the random sampling of
one stay per patient):
- numerical variables are imputed with their median values,
- categorical variables are imputed with their most represented values.
1.3 List of covariates
Table 1 summarizes the concepts used and their basic properties.
2 Details on experiments
2.1 Survival function estimation
For the Cox PH model, the survival P[Ti > t|Xi = xi] for patient i in the test set
is estimated by
Sˆi(t|Xi = xi) = [Sˆcox0 (t)]exp(x
>
i βˆ),
where Sˆcox0 is the estimated survival function of baseline population (x = 0) obtained
using the Breslow estimate of λ0 [1]. For the CURE or the C-mix models, it is
naturally estimated by
Sˆi(t|Xi = xi) = piβˆ(xi)Sˆ1(t) +
(
1− piβˆ(xi)
)
Sˆ0(t),
where Sˆ0 and Sˆ1 are the Kaplan-Meier estimators [2] of the low and high risk of
early-readmission subgroups respectively learned by the C-mix model (patients with
piβˆ(xi) > 0.5 are clustered in the high risk subgroup, others in the low risk one), or
cured and uncured subgroups respectively learned by the CURE model.
2.2 Hyper-parameters tuning
Let us summarize the hyper-parameters obtained after the cross-validation pro-
cedure for each method. First, we take η = 0.1 for all method using Elastic-Net
regularization to ensure covariates selection. The strengh of the penalty is tuned
to 42.81 for LR, 0.05 for SVM, 0.03 for C-mix, 0.008 for CURE and 0.014 for Cox
PH. For RF, the maximum depth is 7, the minium sample’s split is 3, the minimum
sample’s leaf is 2, the criterion is the entropy and the number of estimators is tuned
to 200. For GB, the maximum depth is 7, the minimum sample’s split is 3, the
minimum sample’s leaf is 4 and the number of estimators is 200. Finally for NN,
the hidden layer’s sizes is 3, the regularization term is tuned to 0.13.
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2.3 Covariates importance comparison
Figure 1 gives the covariates importance estimates for all covariates and all consid-
ered methods.
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Figure 1: Comparison of covariates importance, ordered on the C-mix
estimates. Note that for RF and GB models, coefficients are, by con-
struction, always positive.
